baber/WOPTO huggingface dataset:
Patent NZ-543690-A (NZ)
Title: Antibodies that bind to tissue factor, without inhibiting normal tissue factor mediated blood coagulation, and methods of making and methods of use thereof, in the treatment of cancer
Inventor: WANG BAIYANG
IPC: C07K16/36
Filed: 2004-04-21
Abstract: Disclosed is an isolated antibody which binds to human tissue factor encoded by an amino acid sequence of SEQ ID NO:2, wherein said antibody does not inhibit tissue factor mediated blood coagulation compared to a normal plasma control and causes an increase in percent cytotoxicity of tissue factor positive cells compared to negative control antibody.
Patent NZ-544066-A (NZ)
Title: New cytotoxic depsipeptides
Inventor: ROMERO PACO
IPC: C07K5/083
Filed: 2004-06-23
Abstract: Disclosed is a compound of general formula (I) wherein R1 are each independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, nitro, azido, substituted or unsubstituted alkyl, substituted or unsubstituted alkyldiene, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclic group and substituted or unsubstituted acyl; R3 groups are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, nitro, azido, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclic group and substituted or unsubstituted acyl; R4 groups are each independently selected from NR2, O and S; and R2 groups are each independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted alkoxy and substituted or unsubstituted acyl, or a pharmaceutically acceptable salt or stereoisomer thereof. Also disclosed is the use of the above compound, or a pharmaceutically acceptable salt or stereoisomer thereof, in the preparation of a medicament for the treatment of cancer.
Patent NZ-544964-A (NZ)
Title: Aminopeptidase
Inventor: JOLY JOHN C
IPC: C12N9/52
Filed: 2002-09-12
Abstract: Methods for producing N-terminally cleaved polypeptides from cells comprising contacting the peptide with an aminopeptidase encoded by a nucleic acid that has at least an 80% sequence identity to a DNA molecule encoding a native-sequence aminopeptidase b2324 having the sequence of amino acid residues from 1 to 688 of SEQ ID NO:2.
Patent NZ-546153-A (NZ)
Title: Method of increasing the oxidation stability of biodiesel
Inventor: ASBAHR HARK-OLUF
IPC: C07C39/04
Filed: 2006-03-27
Abstract: Disclosed is a method of increasing the oxidation stability of biodiesel which comprises adding at least one primary antioxidant having the structure I to the biodiesel to be stabilised in an amount of from 10 to 20 000ppm (w/w).
Patent NZ-555694-A (NZ)
Title: Cellulosic staple fiber and its use as a filling material
Inventor: KRONER GERT
IPC: D01F2/06
Filed: 2005-12-07
Abstract: The disclosure relates to the use of a multilobal cellulosic staple fiber as a filling fiber. Furthermore, the disclosure relates to a cellulosic staple fiber which is characterized in that - the cross-section of the fiber has three or more lobes, - the cross-section of the fibers is substantially the same throughout the plurality of the fibers, - the titer of the fiber is 1.0 to 30 dtex, preferably more than 3.0 dtex, especially more than 5.0 dtex, preferably 5.6 to 10 dtex, especially preferred more than 6.0 dtex, especially 6.3 to 10 dtex, - the wet modulus of the fiber fulfils the following formula: Wet modulus (cN/tex) is greater or equal to 0.5*square root of T wherein T is the titer of the fiber in dtex, - the breaking strength of the fiber in the conditioned state fulfils the following formula: Breaking Strength (cN/tex) is greater or equal to 1.3*square root of T + 2*T wherein T is the titer of the fiber in dtex. This multilobal cellulosic staple fiber is suitable as a filling material for duvets, cushions, pillows, mattresses, clothing and fleeces for upholstery.
Patent NZ-563783-A (NZ)
Title: Wood preserving antimicrobial composition comprising DCOIT and MI
Inventor: ASHMORE JOHN WILLIAM
Filed: 2006-06-08
Abstract: Disclosed is a synergistic antimicrobial composition comprising: (a) 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one; and (b) 2-methyl-4-isothiazolin-3-one; wherein the composition contains no more than 2% of 5-chloro-2-methyl-4isothiazolin-3-one. This antimicrobial composition is suitable for inhibiting or controlling the growth of microorganisms at a locus and is useful for preserving wood.
Patent NZ-564760-A (NZ)
Title: Stabilization of oxidized fats
Inventor: DULL BOB J
IPC: A23L27/00
Filed: 2006-03-21
Abstract: Disclosed is a method for improving the palatability of a livestock feed or companion animal food product e.g. petfood comprising a basal composition containing unsaturated fatty acids that oxidize to form aldehydes or ketones, said method comprising contacting said basal composition with a source of bisulfite anions so that any aldehydes or ketones present form organosulfite salts wherein said basal composition is extruded to form a dry or semi-dry kibble and is contacted with said bisulfite anion source before being extroded or said bisulfite anion source is applied to the surface of said kibble after it is extruded. Also disclosed is the livestock feed or animal food product produced by said method.
Patent NZ-566248-A (NZ)
Title: Steam-sterilisable blood separating device
Inventor: HEIM GERD H
IPC: A61L2/07
Filed: 2006-07-26
Abstract: A device (1) for separating or fractionating blood into the cellular components of the blood and blood plasma. The device comprises: a filter arrangement (2), which forms an inlet chamber (4) and an outlet chamber (5) by means of filter elements (3) arranged inside; and a receptacle (6) for the cellular blood components; and a receptacle (7) for the blood plasma. The inlet chamber (4) can be connected by a conduit on the entry side to a blood source (10) and is connected on the exit side to the receptacle (6) for cellular blood components. The outlet chamber (5) is connected by a conduit on the exit side to the receptacle (7) for the blood plasma. The conduits consist of flexible plastic tubing with each conduit (17, 20 and 23) being connected to the external environment by a terminating, hydrophobic, porous, water-impermeable and steam permeable bacterial filter (18, 21 and 24). The device is steam sterilisable from within by allowing steam to move into the device via the filters.
Patent NZ-568904-A (NZ)
Title: 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors
Inventor: ALI AMJAD
IPC: A61K31/421
Filed: 2006-12-29
Abstract: Disclosed herein are 1,3-oxazolidin-2-one compounds of formula I, where in Y is -(CRR1)-; X is -O-; Z is -C(=O)-; and the other substituents are as defined within the specification. Such compounds are useful inhibitors of cholesterol ester transfer protein (CETP) and therefore have utility in raising HDL-cholesterol, lowering LDL-cholesterol and in the treatment and prevention of atherosclerosis.
Patent NZ-571322-A (NZ)
Title: Fluid Transfer using capillary action between chambers where the transfer is initiated by a pressure pulse
Inventor: HODGES ALASTAIR MCINDOE
IPC: G01N33/49
Filed: 2007-02-15
Abstract: A fluid transfer device (700) for transferring a fluid from a first chamber (510) to a second chamber (310) is disclosed. A barrier layer between the first and second chamber (310) has at least one opening (410) defining a fluid pathway connecting the first chamber (510) to the second chamber (310). The at least one opening (410) is sized such that a retention force keeps the fluid in the first chamber (510) and the at least one opening (410). At least a portion of the second chamber (310) is movable with respect to the barrier layer and fluid can be transferred from the first chamber (510) to the second chamber (310) via the fluid pathway when that portion of the second chamber (310) contacts the fluid at the at least one opening (410).
Patent NZ-577904-A (NZ)
Title: Vertical filling-packaging machine and method of manufacturing packaging bag
Inventor: TSURUTA ORIHIRO
IPC: B65B9/20
Filed: 2005-03-22
Abstract: A vertical filling-packaging machine comprising: a pair of flat part forming rollers disposed in opposition to each other across a cylindrical film for rotating while sandwiching the cylindrical film to carry the cylindrical film downward while forming a flat part in the cylindrical film; a transverse sealing mechanism disposed below the pair of flat part forming rollers for thermally sealing the flat part formed in the cylindrical film in a width direction thereof; a carrying mechanism for carrying the cylindrical film downward while the pair of flat part forming rollers are not sandwiching the cylindrical film; an introduction nozzle disposed such that a lower end thereof is positioned above the pair of flat part forming rollers for introducing a filler into the cylindrical film from the lower end; and a liquid splash prevention mechanism including a pair of members disposed in opposition to each other across the cylindrical film for nipping the cylindrical film together with a lower end periphery of the introduction nozzle.
Patent NZ-578674-A (NZ)
Title: Reduced irritant enema for the treatment of inflammatory bowel disease (ibd)
Inventor: VENKATARAMAN BALA
IPC: A01N33/02
Filed: 2008-01-29
Abstract: Disclosed is a packaged enema for the treatment of inflammatory bowel disease and related conditions, comprising: an effective and stable dosage suspension of substantially pure 5-ASA contained within a substantially oxygen-free liquid carrier medium, said liquid carrier medium having a material avoidance of antioxidants for said 5-ASA; at least one application bottle containing said effective dosage suspension; a sealed, substantially oxygen-free barrier package containing therein said at least one application bottle containing said effective dosage suspension, and an oxygen scavenger; and said barrier package sufficient to prevent migration of oxygen thereinto and to said dosage suspension upon prolonged storage.
Patent NZ-579429-A (NZ)
Title: Blower with stator component having tube and cage, with rotor supported on bearings within tube
Inventor: KENYON BARTON JOHN
IPC: B28B7/02
Filed: 2008-06-05
Abstract: A blower (l0) includes a stationary portion including an inlet (26) and an outlet (28), a rotating portion provided to the stationary portion, and a motor (40) including at least one magnet adapted to drive the rotating portion. The inlet and outlet are co-axially aligned. The stationary portion includes a housing (20), a stator component (30) provided to the housing, comprising a tube (38) and has a cage surrounding the tube. The rotating portion includes one or more bearings that are provided along the interior surface of the tube to support a rotor within the tube. In an embodiment, the blower is structured to supply air at positive pressure.
Patent NZ-580269-A (NZ)
Title: WEEKLY ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITOR 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
Inventor: OGAWA ATSUSHI
IPC: A61P31/18
Filed: 2008-03-12
Abstract: Disclosed is the use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile (as pictured) in the manufacture of a medicament, when the medicament is adapted to provide a weekly dose of more than 250mg of the compound. Also disclosed a pharmaceutical composition formulated in a single dose form comprising more than 250 mg of the compound. The medicament can be used to treat diabetes.
Patent NZ-585183-A (NZ)
Title: An inhaler clamshell blister pack with a section of the inhaler and a section contating a desicant or other item
Inventor: BERRY SIMON
IPC: B65D75/36
Filed: 2008-11-07
Abstract: An inhaler package comprising a protective enclosure containing an inhaler (20) is disclosed. The protective enclosure has a first rigid enclosure member and a second rigid enclosure member which are attached to each other. Each of the first and second rigid enclosure members defines a recess (100) to house a respective section of the inhaler. A first delimiting member (170a) and a second delimiting member (170b) form a delimited portion, the delimited portion adapted to receive at least one auxiliary feature (160) selected from a desiccant member, a patient information leaflet, a spare mouth piece or a spare canister. The first and second rigid enclosure members each have and opening tab.
Patent NZ-585838-A (NZ)
Title: Delimb Arm Cam Stop
Inventor: SMYTHE JUSTYN P
IPC: A01G23/083
Filed: 2010-06-02
Abstract: Disclosed is a timber-working head which includes a frame, a first delimb arm and a second delimb arm. The first and second delimb arms are pivotally coupled to the frame. Each of the first and second delimb arms includes a delimbing cutting edge. The timber working head further includes a single delimb cylinder mounted to both the first delimb arm and the second delimb arm so as to be floatable relative to the frame. The delimb cylinder is operable to pivot the first and second delimb arms relative to the frame to open and close them. The first and second delimb arms are operatively unconnected from one another allowing pivotal movement of each of the first and second delimb arms without corresponding pivotal movement of the other of the first and second delimb arms. The second delimb arm includes a cam stop defining a variable closure point for the first delimb arm. The first delimb arm is configured to pivot into closed engagement with the cam stop.
Patent NZ-591422-A (NZ)
Title: Multivalent canine vaccines against leptospira bratislava and other pathogens
Inventor: FRANTZ JOSEPH
IPC: A61K39/295
Filed: 2005-09-23
Abstract: A method of protecting a dog against Leptospira bratislava comprising administering to said dog a therapeutically effective amount of a vaccine composition consisting of a Leptospira cell preparation of Leptospira bratislava and one or more of Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona and a carrier, wherein the amount of each Leptospira strain in the vaccine composition is in the range of about 100 to 3500 nephelometric units per vaccine dose.
Patent NZ-591496-A (NZ)
Title: A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
Inventor: ATKINSON HARTLEY CAMPBELL
IPC: A61K31/192
Filed: 2009-10-12
Abstract: Disclosed is the use of paracetamol and ibuprofen in the preparation of a medicament for treating moderate or severe osteoarthritis or moderate or severe rheumatoid arthritis, wherein the medicament comprises a combination composition having approximately 125 mg to approximately 150 mg ibuprofen and approximately 475 mg to approximately 500 mg paracetamol.
Patent NZ-593051-A (NZ)
Title: Cladding system with expressed joint
Inventor: SOUTHWELL DARREN
IPC: E04B2/08
Filed: 2009-12-04
Abstract: 593051 Disclosed is a panelised masonry look wall cladding system incorporating broad planar surfaces, with an vertical expressed shiplapping joint at the sheet edges by maintaining a gap between the bevelled, chamfered or rounded external edges. The wall cladding system includes a plurality of broad rectangular base sheets secured in a side by side vertical orientation to an underlying structure; each of the base sheets having an inner surface and a planar generally smooth unfinished outer surface. Each base sheet is profiled along at least one longitudinal edge to provide, on installation with an adjacent sheet, broad planar surfaces with an intermediate overlapping vertical ship lap expressed joint. A portion of the joint is clearly visible between the outer surfaces of the base sheets and including an interface line defined by an inner overlapping edge of one of the base sheets, the interface line thereby being set in from the outer surfaces of the base sheets. A low build brushable or rollable texture coating applied in situ to the exposed unfinished outer surfaces of the installed base sheets. The visible portion of the expressed joint is defined by a channel formation between the outer surfaces of adjacent base sheets, the channel having an outer width between the outer surfaces, and an inner width at a depth set in from the outer surfaces.
Patent NZ-597891-A (NZ)
Title: In situ precipitation of calcium carbonate (caco3) by indigenous microorganisms to improve mechanical properties of a geomaterial
Inventor: CRAWFORD RONALD L
IPC: C12P3/00
Filed: 2010-05-28
Abstract: Patent No. 597891 Disclosed is a method for increasing the concentration of calcium carbonate in a geomaterial comprising specifically promoting the growth of indigenous alkalinity-tolerant and ureolytic microorganisms within the geomaterial, which promoting comprises adding a source of nutrients and urea to a geomaterial that contains indigenous microorganisms that are capable of hydrolyzing urea to ammonia, and adding a source of calcium ions to the geomaterial thereby promoting the production of calcium carbonate within the geomaterial by the ureolytic microorganisms. Also disclosed is a method for increasing the concentration of calcium carbonate in a geomaterial comprising enriching the geomaterial with a source of nutrients to encourage the growth of microorganisms already contained within the geomaterial, adding urea to the geomaterial, and adding a source of calcium ions to the geomaterial, thereby promoting the production of calcium carbonate within the geomaterial.
Patent NZ-602810-A (NZ)
Title: Printing ink, transfers and methods of decorating polyolefin articles
Inventor: REEVES ROBERT A
IPC: C09D11/00
Filed: 2011-07-27
Abstract: Disclosed herein is printing ink consisting of a mixture of finely subdivided polyethylene powder, an aliphatic or aromatic hydrocarbon solvent, a dispersing agent, an ink additive such as a dye or pigment and/or a physical property enhancing additive such as alumina, glass beads, silica, metal flakes, etc. Preferably high and very high molecular weight polyethylene is used, alone or in mixture with lower density polyethylene in amounts from 25 to 45 weight % in the ink. The polyethylene can have a particle size from 1 nanometer to 150 microns. The printing ink can be used to prepare a transfer having a decorative layer printed onto a carrier sheet. The printed layer is thermally treated to remove hydrocarbon solvent. The transfers are applied to the surfaces of molded polyethylene or polypropylene parts with adequate heat, pressure and time to fuse the transfers into the walls of the parts, as by hot-stamping.
Patent NZ-602981-A (NZ)
Title: NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES
Inventor: DE WIT KELLY
IPC: A61K31/5517
Filed: 2011-06-01
Abstract: ABSTRACT - 602981 The disclosure relates to 5,6-dihydro-4-[(difluoroethyl)phenyl]-4H-pyrrolo[1,2-a][1,4]benzodiazepine and 4-(difluoroethyl)phenyl-6H-pyrrolo[1,2-a][1,4]benzodiazepine derivatives of formula (I) wherein the variables R1, R2, R3, R4, R5 and R6 have the meaning defined in the specification. These compounds are active mainly against dermatophytes and systemic fungal infections. The disclosure further relates to processes for preparing such compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament for the treatment or prevention of a fungal infection caused by one or more of the fungi selected from the group consisting of Candida spp.; Candida parapsilosis; Aspergillus spp.; Cryptococcus neoformans; Sporothrix schenckii; Epidermophyton floccosum; Microsporum spp.; Trichophyton spp; Fusarium spp.; Rhizomucor spp.; Mucor circinelloides; Rhizopus spp.; Malassezia furfur; Acremonium spp.; Paecilomyces; Scopulariopsis; Arthrographis spp.; Scytalidium; Scedosporium spp.; Trichoderma spp.; Penicillium spp.; Penicillium marneffei; and Blastoschizomyces. .
Patent NZ-603226-A (NZ)
Title: Anti-c5a antibodies and methods for using the antibodies
Inventor: SHERIDAN DOUGLAS L
IPC: C07K16/18
Filed: 2011-04-29
Abstract: Disclosed is an isolated antibody or antigen-binding fragment thereof that binds to a free C5a polypeptide, wherein the free C5a is a human polypeptide (hC5a) having the amino acid sequence depicted in SEQ ID NO: 1, and wherein the antibody or antigen-binding fragment thereof binds to the free hC5a polypeptide in vitro with a KD that is less than 1.25 x 10-9 M in the presence of a molar excess of uncleaved, native human C5 and comprises: - a light chain polypeptide comprising: (i) a light chain CDR1 comprising the amino acid sequence depicted by RASESVDSYGNSFMH; a light chain CDR2 comprising the amino acid sequence depicted by RASNLES or WASTRES; and a light chain CDR3 comprising the amino acid sequence depicted by QQSNEDPYT; and - a heavy chain polypeptide comprising: (i) a heavy chain CDR1 comprising the amino acid sequence depicted in DYSMD; a heavy chain CDR2 comprising the amino acid sequence depicted in AINPNSGGTNYNQKFKD or AIHLNTGYTNYNQKFKG; and a heavy chain CDR3 comprising the amino acid sequence depicted in SGSYDGYYAMDY or GFYDGYSPMDY.
Patent NZ-606814-A (NZ)
Title: Methods and compositions for treatment of bone defects with placental cell populations
Inventor: EDINGER JAMES W
IPC: A61P19/00
Filed: 2007-10-23
Abstract: Disclosed is the use of a population of isolated adherent placental stem cells in the manufacture of a medicament for the treatment of a bone defect in a human individual, wherein the bone defect is an osteolytic lesion associated with cancer, a bone fracture, or a spine in need of fusion, wherein said placental stem cells are present in an amount sufficient to treat said bone defect, wherein said placental stem cells express genes at a detectably higher level than an equivalent number of bone marrow-derived mesenchymal stem cells (BM-MSCs), wherein said genes comprise CPA4, TCF21, VTN, B4GALT6, FLJ10781 or NUAK 1, and wherein said placental stem cells are not human totipotent cells.
Patent NZ-607687-A (NZ)
Title: Hob guard
Inventor: PADDOCK MICHAEL THOMAS
IPC: F24C15/36
Filed: 2011-11-30
Abstract: A hob guard for a cooktop (3) is disclosed. The hob guard comprises a substantially U shaped body in plan view with a rear wall (5) and side walls (7, 8) assembled to form a framed perimeter around the cooking surface (3). The side walls (7, 8) comprise an upper rail joined to a lower rail wherein the upper rail is angled downwardly towards the lower rail. The rear wall (6) includes a central vertical web and horizontal arms so that when assembled with the side walls (7, 8) the upper and lower horizontal arms receive corresponding upper and lower rail of the side walls (7, 8). The hob guard may be pivoted about a support surface (2).